LOWER HEALTH CARE COSTS ACT

Bills and resolutions

Enact (see S. 1895), S3843 [19JN]

Remarks in Senate

Enact (S. 1895), S4710 [9JY], S4752, S4755 [10JY], S4834 [16JY], S5158, S5165–S5167 [30JY], S5436 [11SE], S6527 [13NO]

FDA: prohibit abusive delay tactics by pharmaceutical companies to block entry of generic drugs and biosimilar biological products from the market, S5158 [30JY], S6527 [13NO]

——— require manufacturers of approved biological products to disclose and list patents, biosimilarity, and exclusivity information relative to their products and promote biosimilar competition, S5158 [30JY], S6527 [13NO]

Insurance: ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees, S5158 [30JY]

Reports filed

Provisions: Committee on Health, Education, Labor, and Pensions (Senate) (S. 1895), S4698 [8JY]

Statements

Provisions: Senator Alexander, Committee on Health, Education, Labor, and Pensions (Senate), S4623 [27JN]